Bas Koster

MSC.

20122019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

Unlocking the therapeutic potential of primary tumor-draining lymph nodes

Rotman, J., Koster, B. D., Jordanova, E. S., Heeren, A. M. & de Gruijl, T. D., 1 Oct 2019, In : Cancer Immunology, Immunotherapy. 68, 10, p. 1681-1688 8 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Local adjuvant treatment with low-dose CpG-B offers durable protection against disease recurrence in clinical stage I–II melanoma: Data from two randomized phase II trials

Koster, B. D., Van Den Hout, M. F. C. M., Sluijter, B. J. R., Molenkamp, B. G., Vuylsteke, R. J. C. L. M., Baars, A., Van Leeuwen, P. A. M., Scheper, R. J., Petrousjka van den Tol, M., Van Den Eertwegh, A. J. M. & De Gruijl, T. D., 1 Oct 2017, In : Clinical Cancer Research. 23, 19, p. 5679-5686 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Melanoma sequentially suppresses different DC subsets in the sentinel lymph node, affecting disease spread and recurrence

Van Den Hout, M. F. C. M., Koster, B. D., Sluijter, B. J. R., Molenkamp, B. G., Van De Ven, R., Van Den Eertwegh, A. J. M., Scheper, R. J., Van Leeuwen, P. A. M., Van Den Tol, M. P. & De Gruijl, T. D., 1 Nov 2017, In : Cancer Immunology Research. 5, 11, p. 969-977 9 p.

Research output: Contribution to journalArticleAcademicpeer-review